Dr. Willmar Schwabe India has acquired Sanat Products Ltd.
Dr. Willmar Schwabe India, a subsidiary of the German Dr. Willmar Schwabe Group, has acquired Sanat Products Ltd.
Dr. Willmar Schwabe India is engaged in the manufacturing of homeopathic medicines, herbal medicines, specialty formulations and cosmetic products. Dr. Willmar Schwabe Group, based in Germany, is present on five continents. The Schwabe Group comprises several different affiliated companies in the pharmaceutical and health industry. All of the companies within the group focus on plants as the basis for developing their products.
Founded in 1984, Sanat Products Ltd. is a leading manufacturer, supplier and exporter of herbal extracts, ethical products and consumer products. The herbal extracts division (HED) is engaged in the extracting and marketing of standardized herbal extracts to meet the needs of the pharmaceutical, cosmetic, ayurvedic and food industries. The ethical products division (EPD) – prescription-based drugs – offers more than 25 products across a therapeutic mix covering significant chronic and acute segments. These products include dental, oncology, gynecology, diabetes, cardiovascular diseases, dermatology and pain management. The consumer products division (CPD) offers nutraceuticals under brands such as Sunova Bioslim, Sunova Spirulina, Sunova Dr. Shugar, Sunova Curcumin, Uplat and Turmix.
Oaklins’ team in India advised the buyer in this transaction.
Talk to the deal team
Oaklins YES Securities
Gilde Healthcare has invested in Tandarts Today
Gilde Healthcare has invested in Tandarts Today, a fast-growing dental chain in the Netherlands. The investment will allow Tandarts Today to accelerate its buy-and-build strategy and become a leading dental chain in the Netherlands. Financial details have not been disclosed.Learn more
Alcidion (ASX:ALC) has acquired ExtraMed
Alcidion (ASX:ALC) has acquired ExtraMed Ltd., a UK provider of patient flow management software that helps address key pain-points for hospital administrative staff.Learn more
Alcidion (ASX:ALC) has completed a capital raise
Alcidion (ASX:ALC) has raised funds to continue its growth strategy.Learn more